Skip to main content
Decorative image of the AMR Learning Lounge

Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients

SUMMARY

A research study of ICU patients across 12 European hospitals, led by the University of Oxford, provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections. The findings challenge the traditional view that AMR emerges from pathogens that acquire new mutations and the results suggest that interventions aimed at limiting the spread of bacteria between patients may provide a powerful approach to combat AMR. 

FEATURED EXPERT

Julio Diaz Caballero, University of Oxford, Department of Biology, England

Rachel M. Wheatley, University of Oxford, Department of Biology, England


GET STARTED

Read the study at Nature Communications.

Read time: 37 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


Global solutions

BIOMÉRIEUX EPISEQ®

Provides easy-to-use applications for clinical microbiologists: bacterial and fungal identification, clinical pathogen outbreak management, microbiome profiling, and SARS-CoV-2 genomics variants identification.

U.S. bioMérieux Solutions

Us solutions

BIOMÉRIEUX EPISEQ®

Provides easy-to-use applications for clinical microbiologists: clinical pathogen outbreak management, microbiome profiling, and SARS-CoV-2 genomics variants identification.

PUBLISHED BY

Nature Communications
July 12, 2023


SHARE THIS ARTICLE: